Anika Therapeutics reported $0 in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acorda Therapeutics ACOR:US $ 168.37M 2.2M
Adamas Pharmaceuticals ADMS:US 126.16M 148K
Agenus AGEN:US $ 18.91M 0.03M
Agios Pharmaceuticals AGIO:US $ 0.25M 0.08M
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Chemocentryx CCXI:US $ 24.48M 6.38M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Enanta Pharmaceuticals ENTA:US $ 1.48M 0M
Flexion Therapeutics FLXN:US $ 205.03M 1.87M
Halozyme Therapeutics HALO:US $ 784.73M 784.73M
Immunogen IMGN:US $ 0M 0M
Insmed INSM:US $ 375.99M 4.96M
Integra Lifesciences IART:US $ 1.48B 76.69M
Intrexon XON:US $ 174.16M 2.64M
Karyopharm Therapeutics KPTI:US $ 241.79M 50.78M
Ligand Pharmaceuticals LGND:US $ 352.31M 89.98M
Macrogenics MGNX:US $ 0 0
Merit Medical Systems MMSI:US $ 312.88M 30.85M
Peregrine Pharmaceuticals PPHM:US $ 96.95M 96.95M
Rigel Pharmaceuticals RIGL:US $ 19.84M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Stryker SYK:US $ 13059M 171M
Surmodics SRDX:US $ 0M 0M
Veracyte VCYT:US $ 0.86M 0.05M
Xencor XNCR:US $ 0M 0M